Femasys Secures Regulatory Approval for FemBloc® Permanent Birth Control in New Zealand
On Sept. 8, 2025, Femasys announced it has received approval from the New Zealand Medicines and Medical Devices…
-
-
Femasys Announces Historic Milestone with European Approval of FemBloc®, the First Non-Surgical Permanent Birth Control
On Jun. 25, 2025, Femasys announces Conformité Européene (CE) mark certification under European Union Medical Device Regulation of…
-
First hormone-free male birth control pill clears another milestone
On Mar. 26, 2025, research from the University of Minnesota College of Pharmacy, published in Communications Medicine, laid…
-
Biology | FDA | Women's Health
FDA required the first patient package insert: oral contraceptives must contain information for the patient about specific risks and benefits
In 1970, the U.S. Food and Drug Administration (FDA) required the first patient package insert: oral contraceptives must contain…
